Abraxis Pharmaceutical Products (Nasdaq: ABBI) today announced it has received approval from the Food and Drug Administration for two products ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE